Quest Diagnostics (DGX): STATE STREET CORP discloses a stake of more than 5% (Schedule 13G)
Not investment advice. Muhabbit scores how much a story may matter, not which way to trade.
State Street Corp. disclosed a stake exceeding 5% in Quest Diagnostics (DGX) via a Schedule 13G filing with the SEC (accession 0000093751-26-000709). The filing signals that State Street's position has crossed the 5% beneficial ownership threshold, making it a reportable large shareholder in the diagnostic testing company. The exact share count and percentage were not specified in the headline disclosure. The move matters because 13G filings are closely watched for shifts in institutional ownership, which can influence governance and voting dynamics at the company. Investors will watch for the full filing details, including the precise stake size and any subsequent 13G amendments that reveal whether State Street adds to or trims the position.
Muhabbit's AI wrote this summary in its own words from SEC EDGAR SCHEDULE 13G's report. It can get details wrong, so check the source.
Named in this story
Quest Diagnostics (DGX), State Street Corp
A linked name opens that asset's sentiment page.